Genea Biomedx

Martin brings nearly 30 years of commercial leadership experience across Fertility, IVF, Genomics, and Life Sciences. With an academic background in Mechanical Engineering, he has focused his career on driving innovation and improving clinical and laboratory outcomes. Martin began his career at Research Instruments, commercialising micromanipulators and micropipette technologies used widely in IVF laboratories. He then moved into emerging fertility technologies, playing key commercial roles in the introduction of laser‑assisted hatching, embryo biopsy systems, and early RFID witnessing solutions designed to enhance traceability and safety within IVF clinics. More recently, Martin spent over 12 years at CooperSurgical Fertility Solutions, where he played a key role in portfolio consolidation during acquisitions and aligning product strategy, commercial execution, and customer continuity globally. He has subsequently held senior international leadership roles, with a strong focus on sustainable growth, customer partnership, and long‑term value creation.

Teija Peura’s background is in academic science, with a PhD and post-doctoral roles in animal reproductive biotechnology in Finland and Australia. Since 2003, she has transitioned from the Sydney IVF/Genea R&D lab to leading Biomedx product development, then into business development, and eventually returning to a scientific role.

Tom Beckitt, with expertise in Biochemistry, Chemistry, and Clinical Trials, has extensive experience in the pharmaceutical, veterinary, and medical device industries in the UK and Australia. He specialises in drug discovery, vaccine development, and assisted reproductive technologies. Since joining Genea Biomedx in 2015, he has played a key role in the strategic growth and development of the company.

John Kwok is a seasoned executive with over 15 years of leadership experience across the pharmaceutical, biotechnology, and medical-device industries. At Genea Biomedx, he leads the company’s Asia-Pacific operations, driving commercial strategy, market expansion, and operational excellence across the fertility technology landscape. John works closely with global and cross-functional teams to align regional priorities with innovation, R&D, and product development initiatives. Before joining Genea Biomedx, he held senior management roles at Abbott, Sanofi Genzyme, and MSD, where he built high-performing teams and delivered sustained growth across the Asia-Pacific region. John holds a BSc in Pharmacology from the University of Liverpool.

Manuel Llave is a highly experienced and internationally oriented Chief Financial Officer with over two decades in finance, M&A, ERP implementation (SAP S4/HANA, Netsuite), and strategic leadership. Proven track record across healthcare, biotech, manufacturing, and EdTech sectors. Led global expansions, financial system overhauls, investor relations, and multi-million euro funding initiatives. Manuel spent 17 years at IVI RMA Global, the world’s leading assisted reproduction group, playing a pivotal role in its transformation from a small Spanish medical group (5 clinics, €22M revenue) into a global leader with 55 clinics across 15 countries and over €330M in revenue. Manuel hold MBA degree from ESADE and a Bachelor’s in Economics from the University of Valencia.

With a background in biotechnology and biomedical science, Heny is a dynamic and performance-driven professional with over a decade of experience in the global genomics and diagnostics landscape, with expertise especially in the APAC region. She expands our global footprint by building strategic global partnerships and penetrating new regional markets.